Psoriasis Clinical Trial
Use of Telemedicine to Address ‘Off Target’ Symptoms in Psoriatic Arthritis (PsA)
Summary
This will be a single-arm interventional study to test the acceptability, feasibility, and effectiveness of structured telemedicine visits to encourage lifestyle changes that will improve quality of life, disease impact, and disease activity in patients with psoriatic arthritis (PsA).
Full Description
The proposed trial will be embedded within clinical care. This is a 2-year interventional trial that will enroll patients with active psoriatic arthritis despite stable therapy among three centers (the University of Pennsylvania, University of Utah, and University of Oxford). The intervention employs PsOWellTM, a program that trains clinicians to utilize motivational interviewing to help patients set goals and make lifestyle/behavior changes for holistic management of psoriasis.
Eligibility Criteria
Inclusion Criteria:
Population: Patients with Psoriatic Arthritis
Age 18-89.
Active symptoms of PsA as defined by a PsA Impact of Disease (PsAID) questionnaire score >4 (range 0-10, 4 is the patient acceptable symptom state) or a patient global assessment of greater than 4 (scale 0-10).
Patients should be stable on therapy (i.e., not planning to switch therapy at the current visit).
Meet CASPAR criteria.
Provision of signed and dated informed consent form.
Willingness to comply with all study procedures and availability for duration of the study.
Has access to a mobile phone or other mobile device.
Exclusion Criteria:
Inability to provide informed consent.
Plan to change systemic treatment for psoriasis or PsA in the next 4-8 weeks.
PsAID score ≤4
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 2 Locations for this study
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.